Medtech secures £3.8m in new funding round
A medtech spinout from the University of Warwick has secured £3.8m in a new round of funding.
The bulk of the funding - £2.5m - in Medherant has been supplied by specialist technology funder, Mercia Technologies.
Medherant is developing an innovative transdermal drug delivery patch technology.
Henley-in-Arden-based Mercia’s investment is alongside both private investors and other current shareholders.
Mercia’s direct equity shareholding has now risen from 11.3% to 32.4%. This new funding will support Medherant as it ... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
